Seattle, WA, United States of America

Nobuo Hanai

This inventor holds 1 USPTO granted patent. Top assignee: The Biomembrane Institute. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nobuo Hanai. Retrieved from https://idiyas.com/inventor/nobuo-hanai-4fac0684

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nobuo Hanai: Innovator in Glycosphingolipid Research

Introduction

Nobuo Hanai is a notable inventor based in Seattle, WA, recognized for his contributions to the field of glycosphingolipid research. His innovative work has led to the development of a patent that focuses on naturally occurring gangliosides and their applications in cell growth stimulation.

Latest Patents

Hanai holds a patent for "Naturally occurring gangliosides containing de-N-acetyl-sialic acid." This patent outlines a method for preparing de-N-acylated forms of an N-acyl sugar-containing glycosphingolipid. It describes the hydrolysis of glycosphingolipids under mild alkaline conditions, allowing for the preferential hydrolysis of the N-acyl group of the sugar moiety. The patent also details the isolation of substantially pure gangliosides containing de-N-acetyl-sialic acid from natural sources. Furthermore, it introduces a culture medium designed to stimulate the growth of human and animal cells, which includes essential nutrients and a cell growth stimulatory amount of gangliosides. Additionally, the patent presents a medicament and method for stimulating or inhibiting the growth of human and animal cells by influencing the production of growth stimulators.

Career Highlights

Nobuo Hanai is affiliated with The Biomembrane Institute, where he continues to advance research in his field. His work has significant implications for cell biology and therapeutic applications, particularly in the context of human and animal cell growth.

Collaborations

Hanai has collaborated with esteemed colleagues such as Sen-Itiroh Hakomori and Gustavo A Nores, contributing to the advancement of knowledge in glycosphingolipid research.

Conclusion

Nobuo Hanai's innovative work in the field of glycosphingolipids has led to significant advancements in cell growth stimulation. His contributions continue to impact research and applications in cell biology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…